Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, COVID-19, Chills, Myalgia, Nasal congestion
Clinical narrative: tested positive for COVID on 10/9; congestion; First night fever was 103.5; Continues to have body aches; chills (particularly in the evening); This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID on 10/9), NASAL CONGESTION (congestion), PYREXIA (First night fever was 103.5), MYALGIA (Continues to have body aches) and CHILLS (chills (particularly in the evening)) in a 64-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch nos. AS7144B, 065K21A, 033F21A, 009C21A and 006B21A) for COVID-19 prophylaxis.     The patient's past medical history included COVID-19 on 29-May-2021. Previously administered products included for Product used for unknown indication: flu vaccine on 07-Sep-2022. Past adverse reactions to the above products included No adverse event with flu vaccine. Concurrent medical conditions included Environmental allergy and Blood cholesterol abnormal. Concomitant products included ROSUVASTATIN for Blood cholesterol abnormal.   On 25-Mar-2021, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 27-Apr-2021, received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to .5 milliliter. On 05-Nov-2021, received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to .25 milliliter. On 27-Apr-2022, received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to .25 milliliter. On 07-Sep-2022, received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to .5 milliliter. In 2022, the patient experienced NASAL CONGESTION (congestion), PYREXIA (First night fever was 103.5), MYALGIA (Continues to have body aches) and CHILLS (chills (particularly in the evening)). On 09-Oct-2022, the patient experienced COVID-19 (tested positive for COVID on 10/9). At the time of the report, COVID-19 (tested positive for COVID on 10/9), NASAL CONGESTION (congestion), PYREXIA (First night fever was 103.5), MYALGIA (Continues to have body aches) and CHILLS (chills (particularly in the evening)) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2022, Body temperature: 103.5. On 09-Oct-2022, SARS-CoV-2 test: (Positive) Positive.         It was reported that patient did not took paxlovid as his primary case physician said that it would not be effective since he took it in early June. Patient to seek medical care by going to emergency room due to high fever, but it broke while waiting to be seen and did not had to get admitted. Patient did not experience similar event in the past. No treatment medications were reported.   This case was linked to MOD-2022-658061, MOD-2022-658064, MOD-2022-658065 (Patient Link).